chimeric antigen receptor T-cells (Aldevron)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namechimeric antigen receptor T-cells (Aldevron)
Drug Alias NameN/A
ClassificationBiologics > Antigen > Tumor antigenCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAldevron
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAldevron
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A